Cabozantinib Hydrochloride is a selective tyrosine kinase inhibitor that functions primarily by inhibiting the MET receptor tyrosine kinase, along with other targets including VEGFR2 and RET. This potent… Read more
Cabozantinib Hydrochloride is a selective tyrosine kinase inhibitor that functions primarily by inhibiting the MET receptor tyrosine kinase, along with other targets including VEGFR2 and RET. This potent antineoplastic agent is approved for the treatment of advanced renal cell carcinoma, hepatocellular carcinoma, and medullary thyroid cancer. This collection includes reference standards for Cabozantinib Hydrochloride API, alongside its pharmacopeial and non-pharmacopeial impurities, metabolites, and stable isotope-labelled compounds. Pharmaceutical laboratories utilize these high-quality materials for critical applications such as impurity profiling, method validation, and routine quality control during drug development and manufacturing processes. By providing accurate characterization for complex analytical testing, these standards ensure the precision and reliability of quantitative measurements required to maintain strict regulatory compliance and product integrity.